DRI
53
5
KLAC
47
4
DVN
21
3
LEG
36
4
SYY
53
4
UNP
52
7
LYB
39
2
HAS
33
3
MCD
52
2
SO
53
-4
MHK
49
4
NEE
50
-5
SCHW
62
-2
MRK
25
-2
SLB
55
2
LRCX
43
-2
XRAY
28
2
CHRW
56
-3
MTB
67
2
HST
49
-9
DRI
53
5
KLAC
47
4
DVN
21
3
LEG
36
4
SYY
53
4
UNP
52
7
LYB
39
2
HAS
33
3
MCD
52
2
SO
53
-4
MHK
49
4
NEE
50
-5
SCHW
62
-2
MRK
25
-2
SLB
55
2
LRCX
43
-2
XRAY
28
2
CHRW
56
-3
MTB
67
2
HST
49
-9
Financhill
Back

Arcturus Therapeutics Holdings Vs. Fulcrum Therapeutics Industry Stock Comparison

Sell
24

ARCT
Arcturus Therapeutics Holdings

Last Price:
16.94
Seasonality Move:
11.22%
Sell
41

FULC
Fulcrum Therapeutics

Last Price:
3.25
Seasonality Move:
57.36%
Sell
24
Arcturus Therapeutics Holdings (ARCT) is a Sell

Is Arcturus Therapeutics Holdings a Buy, Sell or Hold?

  • The current Arcturus Therapeutics Holdings [ARCT] share price is $16.91. The Score for ARCT is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Fulcrum Therapeutics (FULC) is a Sell

Is Fulcrum Therapeutics a Buy, Sell or Hold?

  • The current Fulcrum Therapeutics [FULC] share price is $3.25. The Score for FULC is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • FULC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARCT Stock Price Chart

What is Arcturus Therapeutics Holdings's stock price today?

  • The Arcturus Therapeutics Holdings share price today is $16.91
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARCT is experiencing slight buying pressure.

FULC Stock Price Chart

What is Fulcrum Therapeutics's stock price today?

  • The Fulcrum Therapeutics share price today is $3.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ARCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.92 Sell
Relative Strength Index (14 RSI): 41.59 Sell
Chaikin Money Flow: 48297 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.22 - 19.76) Sell
Bollinger Bands (100): (18.68 - 22.92) Sell

FULC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 44.64 Sell
Chaikin Money Flow: 580092 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.08 - 3.48) Sell
Bollinger Bands (100): (3.28 - 8.54) Sell

ARCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.25 Sell
20-day SMA: 18.18 Sell
50-day SMA: 20.23 Sell
200-day SMA: 26.65 Sell
8-day EMA: 17.32 Sell
20-day EMA: 18.22 Sell
50-day EMA: 19.63 Sell
200-day EMA: 23.98 Sell

FULC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.14 Buy
20-day SMA: 3.28 Sell
50-day SMA: 3.4 Sell
200-day SMA: 7.17 Sell
8-day EMA: 3.16 Buy
20-day EMA: 3.29 Sell
50-day EMA: 4.01 Sell
200-day EMA: 5.98 Sell

Arcturus Therapeutics Holdings Earnings Growth & ARCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.71 per share.

Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and a decrease next year of $0.91 per share.

Arcturus Therapeutics Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Fulcrum Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):